Related Experiment Videos

Cardiovascular systemic invasion by hepatocellular carcinoma: incidence and pattern in a west African population

E A Ayoola1, I O Olubuyide, J Thomas

  • 1Department of Medicine, University College Hospital, Ibadan, Nigeria.

Insights

Cardiovascular system invasion by hepatocellular carcinoma (HCC) is common in Nigerian patients, affecting 44%. This invasion is difficult to detect clinically and does not alter the poor prognosis of liver cancer.

Area of Science:

  • Hepatobiliary Surgery
  • Oncology
  • Cardiovascular Pathology

Background:

  • Hepatocellular carcinoma (HCC) is a primary liver cancer with a significant global burden.
  • Cardiovascular system (CVS) invasion by HCC is a known but infrequently reported complication.
  • Understanding the frequency and impact of CVS invasion is crucial for patient management and prognosis.

Purpose of the Study:

  • To investigate the prevalence of cardiovascular system invasion in patients with hepatocellular carcinoma.
  • To identify any clinicopathological factors associated with CVS invasion.
  • To assess the impact of CVS invasion on the overall prognosis of HCC.

Main Methods:

  • Retrospective autopsy-based study.
  • Inclusion of 81 Nigerian patients diagnosed with hepatocellular carcinoma.
  • Examination for the presence of tumor thrombi or metastases within the cardiovascular system.

Main Results:

  • Cardiovascular system invasion was identified in 36 out of 81 patients (44%).
  • No significant clinicopathological differences were observed between patients with and without CVS invasion.
  • CVS invasion did not demonstrably worsen the prognosis in this cohort of HCC patients.

Conclusions:

  • Cardiovascular system invasion by HCC is a frequent occurrence.
  • Clinical diagnosis of CVS invasion is challenging.
  • While imaging may exclude invasion before hepatic resection, routine screening is unlikely to improve the overall poor prognosis for most HCC patients.

Related Concept Videos